News

The year that has gone by has had a phenomenal impact on the way we perceive things around us. The pandemic, which is still evolving through its numerous variants, has taught us to think out of the box, and...

The technical body of the World Health Organization has confirmed that the COVID-19 vaccines, which the world is using currently, may have to be reworked to ensure their effectiveness against not only Omicron but future variants as well that...

When it comes to cystic fibrosis, which is a debilitating and progressive condition found in around 11000 people in the UK, no cure has been attained. The EC- European Commission, as it has come to notice, has granted a...

SEEQC, which is a digital quantum computing company, and Oxford University have partnered to ensure accelerated use of computing based on the quantum method in the research particularly focused on pharmaceuticals. This collaboration has unfolded since the development time...

With questions being raised on the safety of the only available approved oral antiviral pill for COVID-19 - Molnupiravir, health experts of the country have pointed out that the benefits of the drug outweigh the potential risks it may have in the...

Immune Biosolutions Inc., a clinical-stage company, is pleased to announce that its leading biological drug candidate maintains a potent activity in neutralization assays. Recent results have confirmed that this drug, IBIO123, is capable of neutralizing SARS-CoV-2 (COVID-19) and all...

Symbiosis Pharmaceutical Services (Symbiosis), a fast-growing contract manufacturing organisation (CMO) specialising in sterile manufacture of vaccines, pharmaceuticals and biopharmaceuticals, has announced an expansion of its capabilities to handle novel and emerging treatments, such as viral based gene- and oncolytic-therapies. Headquartered...